163 related articles for article (PubMed ID: 15888029)
1. Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway.
Liu H; Drew P; Gaugler AC; Cheng Y; Visner GA
Am J Transplant; 2005 Jun; 5(6):1256-63. PubMed ID: 15888029
[TBL] [Abstract][Full Text] [Related]
2. Pirfenidone inhibits inflammatory responses and ameliorates allograft injury in a rat lung transplant model.
Liu H; Drew P; Cheng Y; Visner GA
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):852-8. PubMed ID: 16153939
[TBL] [Abstract][Full Text] [Related]
3. Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells.
Hisatomi K; Mukae H; Sakamoto N; Ishimatsu Y; Kakugawa T; Hara S; Fujita H; Nakamichi S; Oku H; Urata Y; Kubota H; Nagata K; Kohno S
BMC Pulm Med; 2012 Jun; 12():24. PubMed ID: 22694981
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis.
El-Gamel A; Awad MR; Hasleton PS; Yonan NA; Hutchinson JA; Campbell CS; Rahman AH; Deiraniya AK; Sinnott PJ; Hutchinson IV
J Heart Lung Transplant; 1999 Jun; 18(6):517-23. PubMed ID: 10395349
[TBL] [Abstract][Full Text] [Related]
5. Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycina.
Tian XL; Yao W; Guo ZJ; Gu L; Zhu YJ
Chin Med Sci J; 2006 Sep; 21(3):145-51. PubMed ID: 17086734
[TBL] [Abstract][Full Text] [Related]
6. Protective function of pirfenidone and everolimus on the development of chronic allograft rejection after experimental lung transplantation.
von Suesskind-Schwendi M; Heigel E; Pfaehler S; Haneya A; Schmid C; Hirt SW; Lehle K
Histol Histopathol; 2016 Jul; 31(7):793-805. PubMed ID: 26707547
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone in restrictive allograft syndrome after lung transplantation: A case series.
Vos R; Wuyts WA; Gheysens O; Goffin KE; Schaevers V; Verleden SE; Van Herck A; Sacreas A; Heigl T; McDonough JE; Yserbyt J; Godinas L; Dupont LJ; Neyrinck AP; Van Raemdonck DE; Verbeken EK; Vanaudenaerde BM; Verleden GM
Am J Transplant; 2018 Dec; 18(12):3045-3059. PubMed ID: 30019840
[TBL] [Abstract][Full Text] [Related]
8. Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism.
Holán V; Pindjáková J; Krulová M; Neuwirth A; Fric J; Zajícová A
Transplantation; 2006 Jun; 81(12):1708-15. PubMed ID: 16794538
[TBL] [Abstract][Full Text] [Related]
9. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
Jin J; Togo S; Kadoya K; Tulafu M; Namba Y; Iwai M; Watanabe J; Nagahama K; Okabe T; Hidayat M; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Sasaki S; Tominaga S; Takahashi K
Respir Res; 2019 Jun; 20(1):119. PubMed ID: 31185973
[TBL] [Abstract][Full Text] [Related]
10. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
Zhou H; Latham CW; Zander DS; Margolin SB; Visner GA
J Heart Lung Transplant; 2005 Oct; 24(10):1577-85. PubMed ID: 16210133
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway.
Sun YW; Zhang YY; Ke XJ; Wu XJ; Chen ZF; Chi P
Eur J Pharmacol; 2018 Mar; 822():199-206. PubMed ID: 29374548
[TBL] [Abstract][Full Text] [Related]
12. Combination Therapy with Pirfenidone plus Prednisolone Ameliorates Paraquat-Induced Pulmonary Fibrosis.
Rasooli R; Pourgholamhosein F; Kamali Y; Nabipour F; Mandegary A
Inflammation; 2018 Feb; 41(1):134-142. PubMed ID: 28921394
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE
Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656
[TBL] [Abstract][Full Text] [Related]
14. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone: a novel potential therapeutic agent in the management of chronic allograft rejection.
Dosanjh A
Transplant Proc; 2007 Sep; 39(7):2153-6. PubMed ID: 17889122
[TBL] [Abstract][Full Text] [Related]
16. Pirfenidone suppresses keloid fibroblast-embedded collagen gel contraction.
Saito M; Yamazaki M; Maeda T; Matsumura H; Setoguchi Y; Tsuboi R
Arch Dermatol Res; 2012 Apr; 304(3):217-22. PubMed ID: 22033529
[TBL] [Abstract][Full Text] [Related]
17. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.
Stahnke T; Kowtharapu BS; Stachs O; Schmitz KP; Wurm J; Wree A; Guthoff RF; Hovakimyan M
PLoS One; 2017; 12(2):e0172592. PubMed ID: 28231275
[TBL] [Abstract][Full Text] [Related]
18. Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice.
Wells SM; Buford MC; Migliaccio CT; Holian A
Am J Respir Cell Mol Biol; 2009 Feb; 40(2):179-88. PubMed ID: 18703795
[TBL] [Abstract][Full Text] [Related]
19. Species differences in expression pattern of arginase isoenzymes and differential effects of arginase inhibition on collagen synthesis in human and rat pulmonary fibroblasts.
Warnken M; Haag S; Matthiesen S; Juergens UR; Racké K
Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):297-304. PubMed ID: 20107769
[TBL] [Abstract][Full Text] [Related]
20. Functional role and species-specific contribution of arginases in pulmonary fibrosis.
Kitowska K; Zakrzewicz D; Königshoff M; Chrobak I; Grimminger F; Seeger W; Bulau P; Eickelberg O
Am J Physiol Lung Cell Mol Physiol; 2008 Jan; 294(1):L34-45. PubMed ID: 17934065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
